These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 16207876)

  • 21. False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease.
    Loring DW; Goldstein FC; Chen C; Drane DL; Lah JJ; Zhao L; Larrabee GJ;
    Arch Clin Neuropsychol; 2016 Jun; 31(4):313-31. PubMed ID: 27084732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.
    Maccioni RB; Lavados M; Guillón M; Mujica C; Bosch R; Farías G; Fuentes P
    Neurobiol Aging; 2006 Feb; 27(2):237-44. PubMed ID: 16399209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
    Cenini G; Sultana R; Memo M; Butterfield DA
    J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
    DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
    Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
    Owen JB; Di Domenico F; Sultana R; Perluigi M; Cini C; Pierce WM; Butterfield DA
    J Proteome Res; 2009 Feb; 8(2):471-82. PubMed ID: 19072283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuropsychological impairment in the early Alzheimer's disease].
    Traykov L; Rigaud AS; Cesaro P; Boller F
    Encephale; 2007; 33(3 Pt 1):310-6. PubMed ID: 17675928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.
    Mesulam M; Shaw P; Mash D; Weintraub S
    Ann Neurol; 2004 Jun; 55(6):815-28. PubMed ID: 15174015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
    Johnson LA; Hall JR; O'Bryant SE
    PLoS One; 2013; 8(7):e68848. PubMed ID: 23874786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
    Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.
    Pike KE; Savage G; Villemagne VL; Ng S; Moss SA; Maruff P; Mathis CA; Klunk WE; Masters CL; Rowe CC
    Brain; 2007 Nov; 130(Pt 11):2837-44. PubMed ID: 17928318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.
    Sultana R; Perluigi M; Butterfield DA
    Acta Neuropathol; 2009 Jul; 118(1):131-50. PubMed ID: 19288120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
    Egerházi A; Berecz R; Bartók E; Degrell I
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):746-51. PubMed ID: 17289240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis.
    Weamer EA; Emanuel JE; Varon D; Miyahara S; Wilkosz PA; Lopez OL; Dekosky ST; Sweet RA
    Int Psychogeriatr; 2009 Feb; 21(1):78-85. PubMed ID: 18814807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease.
    Arnáiz E; Almkvist O
    Acta Neurol Scand Suppl; 2003; 179():34-41. PubMed ID: 12603249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease?
    Meyer JS; Xu G; Thornby J; Chowdhury MH; Quach M
    Stroke; 2002 Aug; 33(8):1981-5. PubMed ID: 12154249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.
    Hird MA; Egeto P; Fischer CE; Naglie G; Schweizer TA
    J Alzheimers Dis; 2016 May; 53(2):713-29. PubMed ID: 27176076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression.
    Shan X; Chang Y; Lin CL
    FASEB J; 2007 Sep; 21(11):2753-64. PubMed ID: 17496160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease.
    Guidi I; Galimberti D; Lonati S; Novembrino C; Bamonti F; Tiriticco M; Fenoglio C; Venturelli E; Baron P; Bresolin N; Scarpini E
    Neurobiol Aging; 2006 Feb; 27(2):262-9. PubMed ID: 16399211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.
    Wang J; Xiong S; Xie C; Markesbery WR; Lovell MA
    J Neurochem; 2005 May; 93(4):953-62. PubMed ID: 15857398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.